BHRC BLOG
Under-Eye Bags & Dark Circles — What Actually Works
Under-Eye Bags & Dark Circles
Four different problems produce the same complaint, and only one of them is a filler problem. Here is how to tell which you have before anyone injects anything.
1. Work out which problem you have first
This is the whole article. Everything else follows from it.
You can narrow it down yourself in about thirty seconds:
- The stretch test. Gently stretch the skin under your eye. True pigmentation stays put. Shadowing improves or vanishes. A violet tone appearing on stretch points to thin skin over vasculature.
- Change the light. Stand under a different lamp, or tilt your chin up. A shadow moves. Pigment does not.
- Look at the rest of your face. If your cheeks have flattened, the hollow under your eye may be the top of that problem rather than its own.
2. Pigmented dark circles
Periorbital hyperpigmentation is genuine melanin in the skin, and it is disproportionately common in Fitzpatrick IV–VI. The causes worth knowing: genetics; dermal melanocytosis; post-inflammatory pigment from atopic or allergic dermatitis and the rubbing that goes with it; an extension of a pigmentary demarcation line; and drug-induced pigment — including from prostaglandin-analogue lash serums, which surprises a lot of people.
What works: topical depigmenting agents — hydroquinone, kojic acid, azelaic acid, tretinoin, arbutin, vitamin C — used consistently over months; superficial peels; and specific wavelengths, with Q-switched ruby at 694 nm described as a first-line laser for pigmented circles and 1064 nm Nd:YAG used for deeper dermal pigment.
What does not work: filler. It adds volume beneath pigment that is sitting in the skin above it. In darker skin it can also make things worse, because every energy-based or inflammatory intervention in this group carries post-inflammatory hyperpigmentation risk — which is why the literature recommends priming with tretinoin or hydroquinone for two to four weeks before any peel. We cover that protocol in the chemical peel guide.
3. Vascular dark circles
Thin lower-eyelid skin over a rich superficial vascular network reads as blue, purple or pink. It often fluctuates — worse when tired, worse around menstruation, worse with allergies.
What works: vascular-targeting lasers — Nd:YAG 1064 nm, pulsed dye, IPL — and anything that genuinely thickens the dermis over time.
4. Structural hollowing — and the approvals nobody has caught up with
This is the one filler genuinely treats, and the regulatory picture changed recently enough that most articles on the subject are out of date.
Two precision points. The approved wording is “infraorbital hollowing” — “tear trough” is a colloquial term that appears nowhere in the labelling, so “FDA-approved for tear troughs” is not accurate. And note that the FDA’s own consumer-facing filler page still lists the periorbital area among sites it advises against, and has not been updated for these three approvals — the underlying approval records are the better source.
But here is the clinical point that matters more than the approvals: under-eye hollowing is very often a midface problem presenting one level higher. As the medial and lateral midface fat compartments deflate and descend, the lid–cheek junction deepens and the hollow lengthens. Filling the trough directly, without restoring the platform underneath it, means placing more product into the least forgiving area on the face to compensate for a deficit that originates a centimetre lower.
The published guidance is explicit about the importance of midface volumisation in improving infraorbital outcomes. Treating the cheek first frequently reduces the hollow — and reduces or removes the need to inject the tear trough at all.
So if you come in about your under-eyes and we recommend treating your cheeks, that is not an upsell. It is the standard of care, and it is the lower-risk route. Our facial balancing guide works through the sequencing.
5. The risks, stated plainly
We are going to be direct about this, because the area deserves it.
Why the anatomy is unforgiving. The angular artery, the infraorbital artery and the dorsal nasal and supratrochlear vessels all anastomose with branches of the ophthalmic artery. Filler injected under pressure into a distal branch can travel retrograde; when injection pressure stops, normal flow carries it forward — potentially into the central retinal artery. A review of 511 published cases from 1906 to 2023 found 68.2% had no vision recovery, 25.8% partial and 6.0% complete. Retrobulbar hyaluronidase helped in only 2 of 38 cases.
Malar oedema is the more likely problem and the one people are least warned about. The malar septum limits drainage, hyaluronic acid is strongly hydrophilic, and lower-lid lymphatic drainage is limited at baseline — so fluid can sit there. Pooled data puts swelling at 19.2% and one reference reports malar oedema in up to 11% of tear-trough cases. There is a counterintuitive trade-off in the literature worth knowing: a meta-analysis of sixteen prospective trials found oedema in 54.7% with a cannula versus 21.7% with a needle, while bruising ran 1.6% with a cannula versus 22.8% with a needle.
6. The non-filler options, honestly graded
- RF microneedling — the best-documented non-filler option for texture. A prospective split-face trial in 21 women, three sessions at two-month intervals, found periorbital wrinkles improved 8.55% versus 1.07% on the control side, with global assessment also improving. Notably the melanin index did not change significantly — so it helps texture, not pigment.
- PRP — plausible, low-risk, poorly standardised. A 2025 systematic review found some signal but concluded the evidence is “currently very limited,” with small samples, no standardisation of preparation and short follow-up. It does not replace volume. Our PRP guide grades it by indication.
- Lasers — effective, but only when matched to the cause. A laser aimed at the wrong mechanism does nothing.
- Sleep, allergies and salt. Unglamorous, free, and genuinely the first thing to address if your circles fluctuate day to day.
7. What it costs at BHRC
| What you book | Price |
|---|---|
| Filler | from $900 per syringe |
| PRP | from $950 |
| Morpheus8 | from $500 |
Rejuvenation Club members save 20% on every treatment plus priority scheduling. Which of these is right depends entirely on which of the four problems you have — which is why this is one of the consultations we most strongly prefer to do in person.
8550 Santa Monica Blvd, Suite 101, West Hollywood, CA 90069
(323) 859-1257 · Monday–Friday 9:00 AM – 6:00 PM, Saturday 9:00 AM – 4:00 PM
Megan La Fuente, NP · Medical direction by Dr. Stacey Naito, MD
4.8 stars across 312 verified reviews
Consultations are free and carry no obligation.
Questions we get asked
What actually causes dark circles?
Four different things: true pigment in the skin, visible vasculature under thin skin, a shadow cast by structural hollowing, or a combination. They look similar and need completely different treatments — which is why the diagnosis matters more here than the product.
Is filler approved for under the eyes?
Three are, and this changed recently: Juvéderm Volbella XC (2021), Restylane Eyelight (2023) and RHA Redensity Eye (2026) hold FDA approval for improvement of infraorbital hollowing. Every other filler used there is off-label. Note the approved term is ‘infraorbital hollowing’, not ‘tear trough’.
Why did my under-eye filler go blue?
That is the Tyndall effect — filler placed too superficially under very thin skin scatters blue light back at the observer. It occurs in roughly 0.9% of cases. It is treatable with hyaluronidase, reportedly even years later, and it is best avoided by not using filler on a vascular problem in the first place.
Why does my practitioner want to treat my cheeks?
Because under-eye hollowing is frequently a midface problem showing up one level higher. Published guidance emphasises midface volumisation to improve infraorbital outcomes. Restoring the platform underneath often reduces the hollow — and it is a substantially lower-risk area to treat.
How long does the swelling last?
Longer than most people expect. Pooled data puts swelling or oedema at about 19% and malar oedema at up to 11%. In the FDA pivotal trials, one mild oedema case ran 264 days. This is not an area to treat close to an event.
Is it dangerous?
Serious complications are rare but the under-eye is anatomically continuous with the ophthalmic circulation, so the worst-case outcome is vision loss. Across 511 published blindness cases, 68% had no vision recovery. Nose, glabella and forehead account for most cases, not the tear trough — but the margin for error here is the smallest on the face.
Keep reading
- Under-eye treatments at BHRC
- Facial balancing — why the midface comes first
- Skin discoloration and pigmentation at BHRC
- PRP and PRF — honest evidence by indication
- RF microneedling — the texture option
- Chemical peels — and the priming protocol for pigment
- Dermal fillers at BHRC
Book at any of our six locations
References
- Sarkar R, Ranjan R, Garg S, et al. — Periorbital hyperpigmentation: a comprehensive review. J Clin Aesthet Dermatol 2016;9(1):49–55 — the four-type classification and bedside tests. jcadonline.com
- U.S. Food and Drug Administration — Summary of Safety and Effectiveness Data — Juvéderm Volbella XC for infraorbital hollowing, P110033/S053. accessdata.fda.gov
- U.S. Food and Drug Administration — Summary of Safety and Effectiveness Data — Restylane Eyelight, P040024/S135. accessdata.fda.gov
- U.S. Food and Drug Administration — Summary of Safety and Effectiveness Data — RHA Redensity Eye, P170002/S050. accessdata.fda.gov
- Woodward J, Cox SE, Kato K, et al. — Infraorbital hollow rejuvenation: considerations, complications, and the contributions of midface volumization. Aesthetic Surgery Journal Open Forum 2023;5:ojad016. ouci.dntb.gov.ua
- Liu X, Gao Y, Ma J, et al. — The efficacy and safety of hyaluronic acid injection in tear trough deformity: a systematic review and meta-analysis. Aesthetic Plastic Surgery 2024;48:478–490. link.springer.com
- Doyon VC, Liu C, Fitzgerald R, et al. — Update on blindness from filler: review of prognostic factors, management approaches, and a century of published cases. Aesthetic Surgery Journal 2024;44(10):1091–1104. academic.oup.com
- King M — Management of Tyndall effect. J Clin Aesthet Dermatol 2016;9(11):E6–E8. jcadonline.com
- Wu X, Liu Y, Zhu J, Yu W, Lin X — A prospective trial of the microneedle fractional radiofrequency system in the treatment of infraorbital dark circles. Clin Cosmet Investig Dermatol 2022;15:1293–1300. dovepress.com
- EyeWiki / American Academy of Ophthalmology — Complications of hyaluronic acid fillers — malar oedema, Tyndall effect and vascular events. eyewiki.org
Beverly Hills Rejuvenation Center. This content is for general education and does not create a physician-patient relationship or constitute medical advice. Three hyaluronic acid fillers hold FDA approval for improvement of infraorbital hollowing; all other use in this area is off-label. The periorbital region carries a small but serious risk of vascular complications including vision loss. Candidacy, dosing, results and pricing vary by person and are confirmed at a free consultation. Reviewed by the BHRC clinical team.
